229 related articles for article (PubMed ID: 7930545)
1. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience.
Hudson IR
J Hosp Infect; 1994 Jun; 27(2):81-98. PubMed ID: 7930545
[TBL] [Abstract][Full Text] [Related]
2. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection.
Wenzel RP; Perl TM
J Hosp Infect; 1995 Sep; 31(1):13-24. PubMed ID: 7499817
[TBL] [Abstract][Full Text] [Related]
3. Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents.
Watanakunakorn C; Axelson C; Bota B; Stahl C
Am J Infect Control; 1995 Oct; 23(5):306-9. PubMed ID: 8585642
[TBL] [Abstract][Full Text] [Related]
4. Minimal dose requirements for nasal mupirocin and its role in the control of epidemic MRSA.
Casewell MW; Hill RL
J Hosp Infect; 1991 Sep; 19 Suppl B():35-40. PubMed ID: 1684191
[TBL] [Abstract][Full Text] [Related]
5. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
6. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin].
Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F
Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review.
Boelaert JR
J Chemother; 1994 Apr; 6 Suppl 2():19-24. PubMed ID: 7799051
[TBL] [Abstract][Full Text] [Related]
8. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains in the neonatal intensive care unit: an infection prevention and patient safety challenge.
Reich PJ; Boyle MG; Hogan PG; Johnson AJ; Wallace MA; Elward AM; Warner BB; Burnham CA; Fritz SA
Clin Microbiol Infect; 2016 Jul; 22(7):645.e1-8. PubMed ID: 27126609
[TBL] [Abstract][Full Text] [Related]
9. A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit.
Dupeyron C; Campillo B; Bordes M; Faubert E; Richardet JP; Mangeney N
J Hosp Infect; 2002 Dec; 52(4):281-7. PubMed ID: 12473473
[TBL] [Abstract][Full Text] [Related]
10. Nasal carriage of Staphylococcus aureus and cross-contamination in a surgical intensive care unit: efficacy of mupirocin ointment.
Talon D; Rouget C; Cailleaux V; Bailly P; Thouverez M; Barale F; Michel-Briand Y
J Hosp Infect; 1995 May; 30(1):39-49. PubMed ID: 7665881
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin.
Fawley WN; Parnell P; Hall J; Wilcox MH
J Hosp Infect; 2006 Mar; 62(3):327-32. PubMed ID: 16377029
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review.
Laupland KB; Conly JM
Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis.
Perl TM
Surgery; 2003 Nov; 134(5 Suppl):S10-7. PubMed ID: 14647028
[TBL] [Abstract][Full Text] [Related]
14. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis.
Bloom BS; Fendrick AM; Chernew ME; Patel P
Am J Kidney Dis; 1996 May; 27(5):687-94. PubMed ID: 8629629
[TBL] [Abstract][Full Text] [Related]
15. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients.
Boelaert JR; Van Landuyt HW; Godard CA; Daneels RF; Schurgers ML; Matthys EG; De Baere YA; Gheyle DW; Gordts BZ; Herwaldt LA
Nephrol Dial Transplant; 1993; 8(3):235-9. PubMed ID: 8385291
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.
Dupeyron C; Campillo B; Richardet JP; Soussy CJ
J Hosp Infect; 2006 Aug; 63(4):385-92. PubMed ID: 16772100
[TBL] [Abstract][Full Text] [Related]
17. Overview of the role of mupirocin.
Lamb YJ
J Hosp Infect; 1991 Sep; 19 Suppl B():27-30. PubMed ID: 1684188
[TBL] [Abstract][Full Text] [Related]
18. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.
Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S
J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705
[TBL] [Abstract][Full Text] [Related]
19. Preoperative decolonization of methicillin-resistant Staphylococcus aureus.
Larkin SA; Murphy BS
Orthopedics; 2008 Jan; 31(1):37-41. PubMed ID: 18269166
[No Abstract] [Full Text] [Related]
20. A neonatal specialist with recurrent methicillin-resistant Staphylococcus aureus (MRSA) carriage implicated in the transmission of MRSA to newborns.
Méan M; Mallaret MR; Andrini P; Recule C; Debillon T; Pavese P; Croizé J
Infect Control Hosp Epidemiol; 2007 May; 28(5):625-8. PubMed ID: 17464930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
